Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*

Erstveröffentlichung

2016

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Wendtner, Clemens M.

Hallek, Michael

Fraser, Graeme A. M.

Michallet, Anne-Sophie

Hillmen, Peter

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

Leukemia & Lymphoma ; 57 (2016), 6. - S. 1291-1299. - ISSN 1042-8194. - eISSN 1029-2403

Link to publication

https://dx.doi.org/10.3109/10428194.2015.1128540

Funding information

NCI NIH HHS [P01 CA081534]

Dewey Decimal Group

DDC 610 / Medicine & health

---

Metadata

Show full item record